(S)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
95%
- Product Code: 38165
CAS:
142335-42-0
| Molecular Weight: | 293.3200 g./mol | Molecular Formula: | C₁₅H₁₉NO₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00671683 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of complex organic molecules. Its structure, featuring a tetrahydroisoquinoline core, makes it valuable for constructing biologically active compounds, particularly in the development of pharmaceuticals. The presence of the tert-butoxycarbonyl (Boc) protecting group allows for selective reactions during multi-step synthesis, while the carboxylic acid and hydroxyl groups provide functional handles for further chemical modifications. It is often employed in the preparation of peptide mimetics and other therapeutic agents targeting neurological disorders, given the structural similarity to neurotransmitter analogs. Additionally, its chiral center enables the production of enantiomerically pure compounds, which is crucial for drug efficacy and safety.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €74.79 |
+
-
|
(S)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of complex organic molecules. Its structure, featuring a tetrahydroisoquinoline core, makes it valuable for constructing biologically active compounds, particularly in the development of pharmaceuticals. The presence of the tert-butoxycarbonyl (Boc) protecting group allows for selective reactions during multi-step synthesis, while the carboxylic acid and hydroxyl groups provide functional handles for further chemical modifications. It is often employed in the preparation of peptide mimetics and other therapeutic agents targeting neurological disorders, given the structural similarity to neurotransmitter analogs. Additionally, its chiral center enables the production of enantiomerically pure compounds, which is crucial for drug efficacy and safety.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :